Browse studies
Find your next paid study
4 recruiting studies matching your filters
A Prospective, Multi-center Observational Study Characterizing Clinical Outcomes of Patients Receiving Abrocitinib for Moderate-to-severe Atopic Dermatitis Who Had an Inadequate Response (or Intolerance) to ≤2 Previous Biologic Therapies Approved for Moderate-to-severe Atopic Dermatitis
This is a prospective, multi-center observational study characterizing clinical and patient reported outcomes of patients receiving abrocitinib for moderate-to…
Atopic DermatitisAtopic Dermatitis, UnspecifiedDermatitis, Atopic
Estimated
~$10 – $1,125
PfizerNCT06899204
Phase 2
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Atopic DermatitisAtopicDermatitis+5 more
Estimated
~$10 – $8,750
Apollo Therapeutics LtdNCT07599813
Phase 2
Effects of Treatments on the Microbiome in Healthy Volunteers and Patients With Atopic Dermatitis
Background: \- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study…
EczemaDermatitisSkin Diseases, Genetic+2 more
Estimated
~$10 – $5,625
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT01631617
Observational
Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in the Treatment of Patients With Mild Atopic Dermatitis
Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use …
Dermatitis, AtopicPruritus
Estimated
~$10 – $8,750
Nexgen Dermatologics, Inc.NCT06488742